Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Antony J, Zanini E, Kelly Z, Tan TZ, Karali E, Alomary M, Jung Y, Nixon K, Cunnea P, Fotopoulou C, Paterson A, Roy-Nawathe S, Mills GB, Huang RY, Thiery JP, Gabra H, Recchi C.

EMBO Rep. 2018 Jun 15. pii: e45670. doi: 10.15252/embr.201745670. [Epub ahead of print]

PMID:
29907679
2.

The Tumor-Suppressor Protein OPCML Potentiates Anti-EGFR- and Anti-HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer.

Zanini E, Louis LS, Antony J, Karali E, Okon IS, McKie AB, Vaughan S, El-Bahrawy M, Stebbing J, Recchi C, Gabra H.

Mol Cancer Ther. 2017 Oct;16(10):2246-2256. doi: 10.1158/1535-7163.MCT-17-0081. Epub 2017 Aug 3.

PMID:
28775148
3.

WWOX sensitises ovarian cancer cells to paclitaxel via modulation of the ER stress response.

Janczar S, Nautiyal J, Xiao Y, Curry E, Sun M, Zanini E, Paige AJ, Gabra H.

Cell Death Dis. 2017 Jul 27;8(7):e2955. doi: 10.1038/cddis.2017.346.

4.

Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer.

Matassa DS, Amoroso MR, Lu H, Avolio R, Arzeni D, Procaccini C, Faicchia D, Maddalena F, Simeon V, Agliarulo I, Zanini E, Mazzoccoli C, Recchi C, Stronach E, Marone G, Gabra H, Matarese G, Landriscina M, Esposito F.

Cell Death Differ. 2016 Sep 1;23(9):1542-54. doi: 10.1038/cdd.2016.39. Epub 2016 May 20.

5.

Fire severity, residuals and soil legacies affect regeneration of Scots pine in the Southern Alps.

Vacchiano G, Stanchi S, Marinari G, Ascoli D, Zanini E, Motta R.

Sci Total Environ. 2014 Feb 15;472:778-88. doi: 10.1016/j.scitotenv.2013.11.101. Epub 2013 Dec 10.

PMID:
24334000
6.

The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.

McKie AB, Vaughan S, Zanini E, Okon IS, Louis L, de Sousa C, Greene MI, Wang Q, Agarwal R, Shaposhnikov D, Wong JL, Gungor H, Janczar S, El-Bahrawy M, Lam EW, Chayen NE, Gabra H.

Cancer Discov. 2012 Feb;2(2):156-71. doi: 10.1158/2159-8290.CD-11-0256.

7.

Phenoxy herbicides and soft-tissue sarcomas in female rice weeders. A population-based case-referent study.

Vineis P, Terracini B, Ciccone G, Cignetti A, Colombo E, Donna A, Maffi L, Pisa R, Ricci P, Zanini E, et al.

Scand J Work Environ Health. 1987 Feb;13(1):9-17.

8.

Gas chromatographic determination of vinclozolin and endosulfan in strawberries.

Zanini E, Barberis E, Ronco C.

J Agric Food Chem. 1980 Mar-Apr;28(2):464-6. No abstract available.

PMID:
7391383
9.

[Critical considerations on a case of renal tuberculosis].

Ventura M, Barasolo E, Conti PG, Cagna G, Zanini E.

Minerva Urol. 1974 May-Jun;26(3):126-32. Italian. No abstract available.

PMID:
4424656
10.

[Lymphadenographic study of bladder neoplasms].

Ventura M, Zanini E.

Minerva Urol. 1974 May-Jun;26(3):103-10. Italian. No abstract available.

PMID:
4423356
11.

[Lymphadenography in prostatic cancer].

Ventura M, Zanini E.

Minerva Urol. 1971 Jan-Feb;23(1):18-27. Italian. No abstract available.

PMID:
5568884
12.

[Case of primary reticulosarcoma of the skeleton with generalized onset].

Arena GC, Zanini E.

Ann Radiol Diagn (Bologna). 1971;43(6):439-51. Italian. No abstract available.

PMID:
4948385
13.
14.
15.

[Clinico-pathogenetic considerations on metastases of occult tumors].

Arena GC, Zanini E.

Minerva Med. 1969 Nov 3;60(88):4375-81. Italian. No abstract available.

PMID:
5355686
16.

[A new vasodilator agent derivative of hydroxyephedrine].

DI CIO AV, KLEIN L, ZANINI E.

Prensa Med Argent. 1960 May 27;47:1429-31. Spanish. No abstract available.

PMID:
13722463
17.

[Procaine. Its intraarterial injection].

DI CIO AV, KLEIN L, ZANINI E.

Prensa Med Argent. 1960 Feb 12;47:381-5. Spanish. No abstract available.

PMID:
13816394

Supplemental Content

Loading ...
Support Center